Diabetes Device Engineering | Implanting Cell Replacement Therapies
Viacyte Receives Funding to Continue Developing Beta Cell Therapies - JDRF
Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus | Endocrinology
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
ViaCyte (@ViaCyte) / Twitter
ViaCyte closes $45M financing for stem cell-derived type 1 diabetes therapies - Drug Delivery Business
ViaCyte's Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies - ViaCyte
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical
Pin on Diabetes
CIRM-supported Type I Diabetes treatment enters clinical trials in Europe | The Stem Cellar
JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial — Juicebox Podcast and Arden's Day
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
ViaCyte Announces Second Clinical Trial Site at University of Alberta
ViaCyte Acquires Rights to BetaLogics Assets
First Human Clinical Trial of Stem Cell-Derived Implants For Type 1 Diabetes
ViaCyte Interview on Diabetes Stem Cell Trials & Cool Role of Gore-Tex Tech - The Niche
Finally, a possible long-term treatment for type 1 diabetes | UCI Health | Orange County, CA
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient - The Niche
ViaCyte (@ViaCyte) / Twitter
Product Pipeline for Insulin-Requiring Diabetes Treatments
CRISPR and ViaCyte dose first subject in Phase I T1D therapy trial
Diabetes Device Engineering | Implanting Cell Replacement Therapies
ViaCyte - Posts | Facebook
